How Amiodarone Works in Arrhythmias
Amiodarone is a multi-mechanism antiarrhythmic drug that, despite being classified as Class III, exerts effects across all four Vaughan Williams classes by blocking multiple cardiac ion channels and receptors simultaneously. 1
Primary Mechanisms of Action
Amiodarone's antiarrhythmic effects result from several concurrent actions on cardiac electrophysiology:
Ion Channel Blockade
Potassium channel blockade (Class III effect): This is the predominant mechanism with prolonged administration, lengthening the cardiac action potential and prolonging refractoriness throughout the heart 1
Sodium channel blockade (Class I effect): Blocks sodium channels at rapid pacing frequencies, slowing intracardiac conduction 1
Calcium channel blockade (Class IV effect): Produces negative chronotropic effects in nodal tissues, slowing heart rate and AV nodal conduction 1
Additional Mechanisms
Noncompetitive antisympathetic action (Class II effect): Blocks beta-adrenergic stimulation without competing at receptor sites 1
Vasodilation: Decreases cardiac workload and myocardial oxygen consumption 1
Specific Electrophysiologic Effects
The drug produces distinct effects on different cardiac structures 1:
AV Node Effects:
- Prolongs intranodal conduction (Atrial-His interval)
- Prolongs AV node refractoriness
- Slows conduction through the AV node
Minimal Effects on:
- Sinus cycle length
- Right atrial and ventricular refractoriness
- QTc interval (despite QT prolongation)
- Intraventricular conduction (QRS duration)
- Infra-nodal conduction (His-ventricular interval)
Time-Dependent Differences
A critical distinction exists between IV and oral administration 2:
IV amiodarone: Antiarrhythmic effect occurs in less than 30 minutes, primarily through acute ion channel effects before significant accumulation of the active metabolite (DEA) 2, 1
Oral amiodarone: Maximal Class III effects develop over weeks to months, correlating more closely with accumulation of the metabolite desethylamiodarone (DEA) 1
Clinical Implications
The multi-channel blocking profile explains amiodarone's broad-spectrum efficacy:
- Prevents re-entry: Through prolongation of refractoriness in nearly all cardiac tissues 2
- Suppresses automaticity: Depresses abnormal automaticity in atrial and diseased Purkinje fibers 2
- Rate control: Slows ventricular response in atrial arrhythmias through AV nodal effects 2
Important Caveats
Unlike other Class III agents, amiodarone's effects are not associated with reverse use-dependency, meaning it maintains efficacy at slower heart rates 3. This property, combined with its noncompetitive beta-blockade, explains why it rarely causes torsades de pointes despite significant QT prolongation 2, 3.
The drug's lipophilic nature and iodine content (structural similarity to thyroxine) contribute to its unusual pharmacokinetics and side effect profile, particularly thyroid dysfunction 2.